Chirp, A wheeled roller that relieves back pain, was started by Tate Stock in 2018. As of January 2024, Chirp’s net worth is $40 Million and they’re pulling in a whopping $4 million in annual revenue.
On October 30, 2020, they appeared on season 12 of Shark Tank USA and made a deal with Lori Greiner, for $900,000 for 2% equity. The final valuation was $45 Million, down from the founder’s initial estimate of $36 Million.
Provide relief right where it aches on the back, Chirp is still in business. Their products are available to purchase on the official website.
Chirp Net Worth
| Net worth | $40 Million (2024) |
| Annual Sales Revenue | $4 million (2023) |
| Profits | – |
| Lifetime sales | – |
| Investor | Lori Greiner |
| Founder | Tate Stock |
| Employees | 800 to 1000 |
Chirp Net Worth Timeline
| Net Worth 2024 | $40 Million |
| Net Worth 2022 | $36 Million |
| Net Worth 2021 | $30 Million |
| Net Worth 2020 | $27 Million |
| Net worth valuation in 2020 after appearing on Shark Tank | $36 Million |
| Net worth valuation in 2020 before appearing on Shark Tank | $45 Million |
Chirp Pitch on Shark Tank
| Product | A wheeled roller that relieves back pain |
| Episode | Season 12 Episode 03 |
| Founder | Tate Stock |
| Asked for | $900,000 for 2% equity |
| Company name | Chirp |
| Final deal | $900,000 for 2.5% which must be paid back in 18 months |
| Shark | Lori Greiner |
| Location | USA |
Don’t miss these products from Season 12
Chirp Founder
Chirp was founded by Tate Stock in 2018. He has a patent pending for one of his products. Tate is a very smart inventor. He Chirp’s founder, Tate Stock’s net worth is unknown as of 2024.
Key accomplishments
| Year | Accomplishment |
| 2024 | Chirp recognition in Forbes 30 Under 30 for manufacturing. |
| 2020 | Chirp appeared on Shark Tank. |
Conclusion
From their beginnings on Shark Tank to their current status as a thriving business, they have proven that with the right idea and execution, anything is possible. We can’t wait to see the future for Chirp and its continued success.
